Richard Tanner
@RichCardioMD
Followers
129
Following
443
Media
4
Statuses
54
Consultant Cardiologist, Cork University Hospital, and Mater Private Hospital
Manhattan, NY
Joined October 2021
Residual inflammatory & cholesterol risk after PCI.- 15,494 patients on statin tx.- 40% with elevated hsCRP.- hsCRP >2mg/L independently associated with MACE @ 1 yr.- LDL >70mg/dL not associated with MACE @ 1 yr.- Difference in MACE driven by all-cause mortality & spontaneous MI
1
0
7
RT @EuroInterventio: In this editorial, Prof. Sabaté comments on 3-year outcomes from Tanner et al. on intracoronary brachytherapy for mult….
0
7
0
Does intravascular brachytherapy (IVBT) still have a role in treating in-stent restenosis (ISR)?.Multilayer ISR may be a niche indication for this metal free strategy
1
0
8
RT @IRehabilitation: ➡️The considerable psychological impact of heart disease on patients and their families. 🧠👇
0
5
0
Structural Heart Disease fellowship @MountSinaiHeart complete! Excellent teaching & hands-on experience with MitraClip & TriClip. My sincere thanks to the entire Structural Heart team! @DoctorKini @GilbertTangMD @ParasuramMD @KHERA_MD @LucySafi @georgedangas @SaminSharmaMD
1
1
41
RT @GilbertTangMD: 👏🏼🎉New class of @MountSinaiHeart trained structural ❤️interventionalists + imagers. Ready to help pts from around the 🌎!….
0
7
0
RT @JAHA_AHA: With shared decision-making, patients sometimes prefer PCI over the recommended CABG. @DrAnoop_Koshy @GreggWStone @DoctorKini….
0
5
0
RT @JSharimMD: Orthostatic Hypotension in Adults With Hypertension: A Scientific Statement From the AHA. Risk stratified by drug class 👇 ht….
0
55
0
Delighted to contribute to an expert panel discussion on the lifetime management of aortic stenosis this morning at #NYValves2024.
🫀A distinguished panel of experts examine bioprosthetic valve durability and the lifetime management of #aorticstenosis at this morning’s FDA Town Hall session. 🩺 #NYValves2024 . #CardioX #CardioTwitter #CardioEd #CardioResearch . @TheDoctorMack @aakriti_15 @drroxmehran
1
1
11
RT @GreggWStone: Novel publ in JAHA from our group at Mt Sinai. 3687 pts with MVD and SS >22. Documents for the first time (to my knowledge….
0
50
0
RT @ccclivecases: Watch First LIVE Case in the World of TF-TAVR with the Novel 26mm Evolut FX+ - Tomorrow at 9am EDT..
0
1
0
RT @LucySafi: Grand rounds @MountSinaiHeart with expert panelists Dr. Fuster, Dr Bhatt, Dr Adams, Dr Kini, Dr Lerakis moderated by Dr Stone….
0
4
0
RT @GilbertTangMD: Proud to be @MountSinaiHeart ❤️team FIRST commercial #TriClip G4 T-TEER to Rx primary TR & #2 overall in US. Large anter….
0
15
0
Out now in @JACCJournals, our analysis on the role of inflammation in risk prediction among HBR patients undergoing PCI, led by @manishvinayak .👉 ⬆️ hsCRP is associated with high ischemic but not bleeding events.👉 measuring hsCRP may help guide antiplatelet tx in HBR patients
0
3
18
RT @GilbertTangMD: Amazing redo #TAVR live case #SHA2024 @MBalghith @ccclivecases @MountSinaiNYC @MountSinaiHeart @IcahnMountSinai by @Doct….
0
17
0
RT @GilbertTangMD: Huge milestone @MountSinaiHeart @MountSinaiNYC @IcahnMountSinai as we 📈>💯 #MitraClips #Mitral #TEER in 2023. Congrats o….
0
11
0
RT @DrDamluji: Great #AHA23 so far: @AHA_Research . 🥸8 Trials: 8 take aways below . Read the read👇👇. 1/ATRESIA: . Patients with subclinical….
0
195
0
RT @sarahhudsonuk: Ten current papers for the curious general cardiologist, including semaglutide in HFpEF, IV iron in ambulatory HF pts, a….
0
32
0